As of April 16, 2025, Lantern Pharma (LTRN) has a market cap of $37.746 million USD. According to our data, Lantern Pharma is ranked No.8241 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $37.75 M |
9.72%
|
Dec 31, 2024 | $34.40 M |
-25.47%
|
Dec 29, 2023 | $46.16 M |
-29.14%
|
Dec 30, 2022 | $65.14 M |
-24.31%
|
Dec 31, 2021 | $86.06 M |
-58.55%
|
Dec 31, 2020 | $0.21 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Novartis
NVS
|
$218.28 B |
1.163 B
|
![]() Switzerland
|
![]() Sanofi
SNY
|
$127.25 B |
3.672 B
|
![]() France
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
Market Cap | = | LTRN Stock Price | * | LTRN Shares Outstanding |
= | $3.50 | * | 10.78 M | |
= | $37.75 M |